Table 1. Effects of marijuana or Δ9-THC on circulating gonadotropins, prolactin and ovarian hormones in female humans and rhesus monkeys.
Treatment | Primary outcomes of treatment condition (marijuana or Δ9-THC) | |||||||||||||
Ref | Subjects | Design | Dose | Route | Timing | FSH | LH | E2 | P | PRL | ||||
18 | 5 female rhesus monkeys | repeated measures | Δ9-THC (2.5 mg/kg) or vehicle | IM | daily during the follicular phase | n.d. | Supressed LH surge | Altered patters of circulating total estrogens across the cycle (supressed pre-ovulatory spike) | Suppressed luteal elevation of P | No effect | ||||
20 | 4 female rhesus monkeys | repeated measures | Δ9-THC (2.5 mg/kg) or vehicle | IM | daily during the luteal phase (from the day after ovulation until menses) | n.d. | n.d. | n.d. | No effect | n.d. | ||||
21,22 | 8 healthy human female marijuana users | repeated measures, double blind, placebo controlled | 1-gram standardized marijuana joint (1.83% Δ9-THC) or placebo joint | inh | single dose during follicular phase | n.d. | No effect | No effect | No effect | No effect | ||||
21,22 | 8 healthy human female marijuana users | repeated measures, double blind, placebo controlled | 1-gram standardized marijuana joint (1.83% Δ9-THC) or placebo joint | inh | single dose during luteal phase | n.d. | Decreased 60-120 mins after dose | No effect | No effect | Decreased 60-120 mins and 150-180 after dose. | ||||
24 | 3 female rhesus monkeys | repeated measures | Δ9-THC (2.5 mg/kg) or vehicle | IM | single dose during mid-luteal phase (day 20-22) | n.d. | n.d. | n.d. | Decreased 6-24 hours after dose; effect was prevented by HCG | n.d. | ||||
25 | 5 ovarectomized female rhesus monkeys | repeated measures performed at least 10 days apart | single dose of Δ9-THC (0.3125, 0.625, 1.25, 2.5, 5.0 mg/kg) or vehicle. | IM | Non-cycling animals | Decreased 6-24 hours after 5.0 mg/kg dose, 12 hours after 2.5 mg/kg dose, and 6 hours after 0.625 and 1.25 mg/kg doses. | Decreased 6-12 hours after 2.5 and 5.0 mg/kg doses, and 6 hours after 0.625 and 1.25 mg/kg doses. No effect with 0.3 mg/kg. | n.d. | n.d. | n.d. | ||||
26 | 5 female rhesus monkeys | repeated measures, chronic study | Δ9-THC (1.25 mg/kg in 2 monkeys or 2.5 mg/kg in 3 monkeys) or vehicle | IM | 3X per week beginning on cycle day 1 and lasting for 230 days or until 2 consecutive ovulatory cycles occurred | n.d. | Decreased for ~100 days after treatment began in 2.5 mg/kg treated group | Decreased for ~100 days after treatment began in 2.5 mg/kg treated group | Decreased for ~100 days after treatment began in 2.5 mg/kg treated group | No effect |
Abbreviations: Δ9-THC, delta-9-tetrahydrocannabinol; E2, estradiol; FSH, follicle-stimulating hormone; hCG, human chorionic gonadotropin; IM, intramuscular (injection); inh, inhalation; LH, luteinizing hormone; mg/kg, milligrams (of drug) per kilogram (of body weight); n.d., not determined; P, progesterone; PRL, prolactin